These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37632447)

  • 1. Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples.
    Muratspahić E; White AM; Ciotu CI; Hochrainer N; Tomašević N; Koehbach J; Lewis RJ; Spetea M; Fischer MJM; Craik DJ; Gruber CW
    J Med Chem; 2023 Sep; 66(17):11843-11854. PubMed ID: 37632447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.
    Joshi AA; Murray TF; Aldrich JV
    J Med Chem; 2015 Nov; 58(22):8783-95. PubMed ID: 26491810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
    Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
    J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
    Zhao Y; Joshi AA; Aldrich JV; Murray TF
    Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor.
    Merg F; Filliol D; Usynin I; Bazov I; Bark N; Hurd YL; Yakovleva T; Kieffer BL; Bakalkin G
    J Neurochem; 2006 Apr; 97(1):292-301. PubMed ID: 16515546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationships of [des-Arg
    Ramos-Colon CN; Lee YS; Remesic M; Hall SM; LaVigne J; Davis P; Sandweiss AJ; McIntosh MI; Hanson J; Largent-Milnes TM; Vanderah TW; Streicher J; Porreca F; Hruby VJ
    J Med Chem; 2016 Nov; 59(22):10291-10298. PubMed ID: 27797517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
    Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
    Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
    Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV; Patkar KA; McLaughlin JP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18396-401. PubMed ID: 19841255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance.
    Ito H; Navratilova E; Vagnerova B; Watanabe M; Kopruszinski C; Moreira de Souza LH; Yue X; Ikegami D; Moutal A; Patwardhan A; Khanna R; Yamazaki M; Guerrero M; Rosen H; Roberts E; Neugebauer V; Dodick DW; Porreca F
    Brain; 2023 Mar; 146(3):1186-1199. PubMed ID: 35485490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders.
    Reed B; Butelman ER; Kreek MJ
    Handb Exp Pharmacol; 2022; 271():473-491. PubMed ID: 33174064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Constraint between Aromatic Residue Side Chains in the "Message" Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist.
    Gisemba SA; Ferracane MJ; Murray TF; Aldrich JV
    J Med Chem; 2021 Mar; 64(6):3153-3164. PubMed ID: 33688737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach.
    Clark SD
    Handb Exp Pharmacol; 2022; 271():525-546. PubMed ID: 33459877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands.
    Spetea M; Schmidhammer H
    Handb Exp Pharmacol; 2022; 271():163-195. PubMed ID: 33454858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prelimbic cortex dynorphin/κ opioid receptor system modulates methamphetamine-induced cognitive impairment.
    Cheng YJ; Deng YZ; Deng D; Wu MQ; Chai JR; Wang YJ; Liu JG; Zhao M
    Addict Biol; 2023 Sep; 28(9):e13323. PubMed ID: 37644896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons.
    Moises HC; Rusin KI; Macdonald RL
    J Neurosci; 1994 Oct; 14(10):5903-16. PubMed ID: 7931552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.